15,798 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Purchased by 683 Capital Management LLC

683 Capital Management LLC bought a new stake in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 15,798 shares of the medical instruments supplier's stock, valued at approximately $739,000. 683 Capital Management LLC owned approximately 0.48% of Pro-Dex at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in PDEX. Bank of New York Mellon Corp bought a new stake in shares of Pro-Dex during the fourth quarter valued at approximately $202,000. Trexquant Investment LP acquired a new stake in Pro-Dex in the 4th quarter valued at $252,000. Integrated Quantitative Investments LLC bought a new stake in Pro-Dex during the 4th quarter valued at $254,000. Arrowstreet Capital Limited Partnership acquired a new position in Pro-Dex during the fourth quarter worth $255,000. Finally, Russell Investments Group Ltd. bought a new position in shares of Pro-Dex in the fourth quarter valued at $327,000. 15.28% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Pro-Dex from a "buy" rating to a "hold" rating in a research report on Wednesday, March 12th.

Insider Activity

In other Pro-Dex news, Director Raymond E. Cabillot sold 7,674 shares of Pro-Dex stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $45.00, for a total transaction of $345,330.00. Following the transaction, the director now owns 310,978 shares of the company's stock, valued at $13,994,010. This trade represents a 2.41 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 21,383 shares of company stock worth $1,031,182 over the last quarter. Insiders own 47.50% of the company's stock.

Pro-Dex Stock Down 31.9 %

Shares of Pro-Dex stock traded down $21.44 on Friday, hitting $45.86. The company had a trading volume of 278,434 shares, compared to its average volume of 27,427. Pro-Dex, Inc. has a 1 year low of $16.84 and a 1 year high of $70.26. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. The stock has a 50 day moving average of $52.16 and a 200-day moving average of $45.87. The stock has a market capitalization of $149.55 million, a price-to-earnings ratio of 22.82 and a beta of 0.37.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.51. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. The business had revenue of $17.41 million during the quarter, compared to the consensus estimate of $17.70 million. As a group, sell-side analysts forecast that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Pro-Dex Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.